The aim of the present study was to evaluate whether subclinical left ventricular (LV) systolic dysfunction is independently related to subclinical coronary atherosclerosis in type 2 diabetic patients and if it could provide incremental information over baseline characteristics to identify high-risk patients.
Introduction
Cardiovascular complications, including coronary artery disease (CAD), are the leading causes of morbidity and mortality in individuals with type 2 diabetes. 1 The poor clinical outcome of patients with diabetes underscores the need to develop practical approaches for detecting CAD at an early stage for early initiation of appropriate treatment, which potentially may favourably affect an otherwise poor outcome. 2 However, the detection of CAD in patients with diabetes remains challenging because CAD is often asymptomatic. Non-invasive assessment of the coronary artery calcium (CAC) score, by means of electron-beam computed tomography or multi-slice computed tomography (MSCT); noninvasive imaging of the coronary arteries, by means of MSCT coronary angiography; and myocardial perfusion imaging, by means of single photon emission computed tomography, have been recently proposed to improve identification of asymptomatic diabetic patients at high risk for cardiovascular events. 3 -5 Recently, subtle abnormalities of left ventricular (LV) systolic function have been reported in patients with type 2 diabetes using automated function imaging, a novel method based on twodimensional (2D) speckle-tracking echocardiography. 6 However, in asymptomatic diabetic patients the relation between subclinical LV systolic dysfunction and the presence of coronary atherosclerosis is still unclear. Accordingly, the purpose of the present study was to evaluate whether subclinical LV systolic dysfunction is independently related to coronary atherosclerosis and if it could provide incremental information over baseline characteristics for the identification of asymptomatic diabetic patients having coronary atherosclerosis. Automated function imaging was used to identify the presence of subclinical LV systolic dysfunction, while the presence of coronary atherosclerosis was assessed by means of CAC scoring.
Methods

Patient population
A total of 289 asymptomatic consecutive outpatients with type 2 diabetes underwent CAC scoring for screening of coronary atherosclerosis. Two-dimensional echocardiography was performed in all patients on the same day. Patients with angina or angina-equivalent symptoms, a history of CAD, cardiomyopathy, significant (moderate or severe) valvular heart disease, congenital heart disease, and rhythm other than sinus, or conduction abnormalities were excluded. In addition, patients were excluded in case of a suboptimal echocardiographic window. Asymptomatic status was confirmed using the Rose questionnaire for angina. 7 A history of CAD was defined as the presence of previous acute coronary syndromes, percutaneous, or surgical coronary revascularization or angiographically documented coronary stenosis with ≥50% luminal diameter. 8 Coronary artery calcium score, data acquisition/analysis CAC score was performed using a 64-slice MSCT scanner (Aquilion 64, Toshiba Medical Systems, Tokyo, Japan). For this purpose, a non-enhanced low-dose ECG-gated scan was performed with prospective triggering at 75% of the R -R interval. Scan parameters were as follows: collimation 4 × 3.0 mm, gantry rotation time 0.5 s, tube current 200-250 mA, and tube voltage 120 kV. CAC score was determined by an experienced observer using dedicated software (Vitrea 2, Vital Images, Minnetonka, MN, USA). Total CAC score was calculated for each patient using the Agatston method. 9 The presence of coronary atherosclerosis was defined as a CAC score .0. Figure 1 shows different severity of coronary atherosclerosis based on the CAC score.
Two-dimensional echocardiography, data acquisition/analysis
Two-dimensional echocardiography was performed with the patient in the left lateral decubitus position using a commercially available system (Vivid 7, General Electric Vingmed, Milwaukee, WI, USA) equipped with a 3.5-MHz transducer. Standard M-mode, 2D images and Doppler and colour-Doppler data were acquired from the parasternal and apical views (4-, 2-, and 3-chamber) and digitally stored in cineloop format. Analyses were performed off-line using EchoPAC version 7.0.0 (GE Healthcare, Horten, Norway). LV diameters, and end-diastolic thickness of the interventricular septum and the posterior wall were measured on the parasternal long-axis M-mode recordings. LV end-systolic and end-diastolic volumes were assessed and LVEF was calculated from the apical 4-and 2-chamber views using the Simpson's rule. 10 Subsequently, the LV mass was determined using the formula by Devereux et al. 11 and normalized for body surface area (LV mass index, g/m 2 ). On the basis of the recommendations of the American Society of Echocardiography, diastolic function was evaluated with transmitral and pulmonary vein flow recordings. 12 Diastolic function was then classified as normal, when the E/A ratio ¼ 0.9-1.5, DT ¼ 160 -240 ms, and PVs ≥ PVd.
12
LV global longitudinal strain (GLS) was quantified using automated function imaging, which provides a new imaging technique based on 2D strain imaging. 13 The software analyses motion by tracking speckles (natural acoustic markers) in the 2D ultrasonic image. The frame-to-frame changes of the speckles are used to derive motion and velocity. The methodology has been previously described in detail. 13 This automated algorithm provides the peak systolic longitudinal strain for each LV segment in a 17-segment 'bull's eye' plot, with the average value of peak systolic longitudinal strain for each view and the averaged GLS for the entire left ventricle ( Figure 2 ). In general, the LV GLS values are presented as negative values; a more negative value indicates a larger extent of longitudinal strain.
Statistical analysis
Continuous variables are expressed as mean and standard deviation (SD) and categorical variables are expressed as numbers and percentages. Differences in continuous and categorical variables between Subclinical LV dysfunction and type 2 diabetes patients with and without coronary atherosclerosis were assessed using Student's t-test and the x 2 test, respectively. In addition, the correlation between LV GLS and the CAC score was evaluated with multivariate linear regression analysis correcting for confounding factors (age, gender, hypertension, hypercholesterolaemia, duration of diabetes, LV mass, and diastolic dysfunction). Furthermore, to define intra-observer and inter-observer reproducibility, LV GLS measurements were repeated for 20 randomly selected patients at least 4 weeks apart by the same observer on the same echocardiographic images, and by a second independent observer, blinded to the measurements of the observer 1. Intra-and inter-observer reproducibility of LV GLS measurements were evaluated with Bland -Altman analysis. Finally, univariable and multivariable logistic regression analysis (enter model) were performed to evaluate the association between the presence of coronary atherosclerosis and baseline clinical (age, gender, coronary risk factors, diabetes-related risk factors and complications) and echocardiographic (LV mass index, LVEF, presence of diastolic dysfunction and GLS) characteristics. Only significant (P , 0.05) univariable predictors were entered as covariates in the multivariate model. Odds ratios and 95% confidence intervals were calculated. In order to determine the potential incremental value of the LV GLS over the other selected independent predictors of coronary atherosclerosis, the x 2 distribution of the multivariable model was compared with x 2 distribution of the same model without LV GLS, applying the model x 2 step. In addition, the optimal cut-off value for LV GLS to predict coronary atherosclerosis in asymptomatic, type 2 diabetes patients was determined by receiver operating characteristic (ROC) curve analysis. For risk stratification purposes, the optimal cut-off value was defined as the value that optimized sensitivity to distinguish between asymptomatic, type 2 diabetic patients with and without coronary atherosclerosis. All statistical tests were two-sided and a P-value of ,0.05 was considered statistically significant. Statistical analysis was performed using the SPSS software package (SPSS 16.0, Chicago, IL, USA).
Results
Patient characteristics
From the initial cohort of 289 patients, 35 (12%) had a suboptimal echocardiographic window, precluding reliable automated function imaging analysis, and were not eligible for the study. Consequently, 234 patients were included in the final analysis. The mean age was 52 + 11 years and 134 (57%) patients were male. Almost half of the patients were on insulin therapy. In the total population, average CAC score was 319 + 901 (range 0-8730). CAC was absent in 95 (41%) patients. In the remaining 139 (59%) patients, an average CAC score of 537 + 1120 was observed with 41 (29%) and 19 (14%) patients having a CAC score .400 and .1000, respectively. Baseline and echocardiographic characteristics of the overall study population and of asymptomatic, type 2 diabetic patients with (CAC . 0) and without coronary atherosclerosis (CAC ¼ 0) are summarized in (Table 2) . Finally, Bland-Altman analysis showed good intra-and inter-observer reproducibility for LV GLS measurements with small bias, tight limits of agreement, and no significant trend (0.14 + 0.7 and 20.11 + 0.9%, respectively).
Comparison between patients with and without coronary atherosclerosis
When compared with patients without coronary atherosclerosis (n ¼ 95), patients with coronary atherosclerosis (n ¼ 139) were significantly older and had a longer duration of diabetes (P , 0.001 for both comparisons); in addition, patients with coronary atherosclerosis more frequently had hypertension, hypercholesterolaemia, retinopathy, and polyneuropathy (P , 0.01 for all comparisons). No difference in LVEF was observed between asymptomatic, type 2 diabetic patients with and without coronary atherosclerosis ( Table 1) . In contrast, the prevalence of diastolic dysfunction was significantly higher among patients with coronary atherosclerosis (45 vs. 23%; P ¼ 0.002). Furthermore, the analysis of LV mechanical properties with automated function imaging demonstrated that in patients with coronary atherosclerosis, a more impaired LV GLS (less negative value) was observed when compared with patients without coronary atherosclerosis (216.3 + 3.0 vs. 218.0 + 2.8%; P , 0.001).
Predictors of coronary atherosclerosis
The results of the univariable and multivariable logistic regression analysis performed to identify potential predictors of coronary atherosclerosis are provided in Table 3 . At univariable analysis age, male gender, hypertension, hypercholesterolaemia, duration of diabetes, age at time of diagnosis, retinopathy, peripheral vascular disease, peripheral neuropathy, diastolic dysfunction, and LV GLS were significantly related to coronary atherosclerosis. At multivariable analysis, male gender [odds ratio (OR) ¼ 2.87; 95% confidence interval (CI) 1.46-5.64; P ¼ 0.002], hypertension (OR ¼ 2.38; 95% CI 1.21 -4.69; P ¼ 0.012), hypercholesterolaemia (OR ¼ 2.32; 95% CI 1.18-4.55; P ¼ 0.015), and LV GLS (OR ¼ 2.14; 95% CI 1.09 -4.22; P ¼ 0.028) were independent factors associated with coronary atherosclerosis. As shown in Figure 3 , adding GLS to the other selected independent variables significantly improved the ability to predict coronary atherosclerosis. Finally, ROC curve analysis was performed to obtain a cut-off value of LV GLS to identify asymptomatic type 2 diabetic patients at a high risk of having coronary atherosclerosis. stratification purposes, an LV GLS cut-off value of 218.8% would optimize the sensitivity up to 80% with a low false negative rate (22%).
Discussion
The results of the present study can be summarized as follows: (i) when compared with diabetic patients without coronary atherosclerosis, diabetic patients with coronary atherosclerosis showed an impaired LV GLS, even though the LVEF was still preserved (reflecting the presence of subclinical LV systolic dysfunction); (ii) the presence of subclinical LV systolic dysfunction provides significant incremental value for the identification of patients having coronary atherosclerosis.
Coronary atherosclerosis and subclinical left ventricular systolic dysfunction in diabetes mellitus
In diabetic patients, the diagnosis of CAD is frequently missed or delayed since the typical symptoms of myocardial ischaemia are often masked. Before symptoms of ischaemia occur, diffuse multivessel atherosclerosis is frequently present. It has been shown that risk and mortality from CAD in patients with type 2 diabetes are similar to patients without diabetes and previous myocardial infarction, indicating an increased event risk in diabetic patients. 14 Recent data from the Multi-Ethnic Study of Atherosclerosis trial demonstrated that diabetic patients with a minimal CAC score (1-10) had an increased risk for coronary heart disease events at longterm follow-up (hazard ratio: 1.67, 95% CI 0.36-7.77). 15 In addition, CAD is one of the main causes of overt LV dysfunction and heart failure in this group of patients. 16 Accordingly, early identification of coronary atherosclerosis in asymptomatic diabetics may be beneficial, allowing timely detection of patients at increased risk, and appropriate selection of further diagnostic and therapeutic procedures. Previous studies in the general population have demonstrated that the extent of CAC as assessed with electron-beam computed tomography strongly correlates with the overall magnitude of atherosclerotic plaque burden. 17, 18 The extent of CAC is affected by age, gender, and traditional cardiovascular risk factors. A threshold value of 400 as the cut-point for high risk for obstructive CAD has been found in previous studies. 19 However, such scores are very rare in men ,60 years of age and almost non-existent in women ,65 years of age. In screening for a disease as prevalent as CAD, such stringent criteria for a positive scan may not be appropriate when screening asymptomatic individuals. Echocardiographic techniques have been proposed to detect diabetic cardiomyopathy and the presence of significant CAD early. Diastolic dysfunction is rather common in asymptomatic type 2 diabetic patients. Indeed, sophisticated techniques such as tissue Doppler imaging have demonstrated that as much as 75% of asymptomatic diabetic patients with negative stress echocardiogram show LV diastolic dysfunction. 20 In line with previously published studies, diastolic dysfunction was frequently observed in the present patient population (68%); 21, 22 of note, the prevalence of diastolic dysfunction was higher in diabetics when compared with those without coronary atherosclerosis (75 vs. 56%). Accordingly, diastolic dysfunction was significantly associated with the CAC score index at the univariate analysis. However, LV systolic function as measured with conventional parameters such as the LVEF was not related to the CAC score index. This demonstrates that the LVEF may be an insensitive parameter to detect subtle LV systolic dysfunction. In contrast, sophisticated echocardiographic techniques such as 2D speckle tracking permit detecting subclinical LV systolic dysfunction. In the present study, the LV GLS was impaired in diabetic patients with coronary atherosclerosis when compared with those without (216.3 + 3.0 vs. 218.0 + 2.8%), reflecting the presence of subclinical LV systolic dysfunction. LV GLS was independently related to the presence of coronary atherosclerosis, and provided significant incremental value over other baseline clinical characteristics and LV diastolic dysfunction for the identification of patients having coronary atherosclerosis. Previous studies have underscored the presence of subclinical LV dysfunction in asymptomatic patients with type 2 diabetes. 23, 24 The underlying pathophysiology of diabetic cardiomyopathy includes several processes that act synergistically and, hyperglycaemia is considered as the central factor that triggers several adaptive and maladaptive responses. 25 These responses lead to accelerated apoptosis of the myocardial fibres and replacement fibrosis. Particularly, the deposits of collagen are thought to contribute to arterial and myocardial stiffening and endothelial dysfunction. The subendocardial fibres, oriented longitudinally, are the first to be involved in these processes and, therefore, subclinical LV systolic dysfunction can be identified with the assessment of LV GLS. A reduced GLS indicates, at these early stages, an impairment of the subendocardial shortening. In addition to coronary atherosclerosis, several other clinical parameters may influence longitudinal systolic shortening (such as age, gender, or cardiovascular risk factors). 26 However, the present study demonstrated the independent relationship between subclinical LV dysfunction and asymptomatic coronary atherosclerosis in this group of patients. 27 Edvardsen et al. investigated the relation between the regional coronary calcium score and regional LV systolic strain (assessed by tagged magnetic resonance imaging) in 509 asymptomatic patients without a history of CAD and with a normal LVEF. 28 Although the patients were older and had lower CAC scores when compared with our population, an independent relation between impairment of regional LV systolic function and coronary atherosclerosis was observed.
Study limitations
Some limitations need to be acknowledged. First, plaque composition characterization was not performed in the present study. Current recommendations do not advocate the use of MSCT to evaluate the coronary artery anatomy and the presence of noncalcified plaques in asymptomatic type 2 diabetic patients due to the non-negligible radiation exposure and the use of iodinated contrast. Second, the LV strain in the radial and circumferential directions was not evaluated. The automated algorithm used in the present study only permits the assessment of longitudinal LV strain.
Clinical implications
The results of the present study indicate that LV GLS may allow the identification of subclinical systolic dysfunction in diabetic patients, possibly related to the presence of subclinical coronary atherosclerosis. As mentioned before, the poor clinical outcome in patients with type 2 diabetes underscores the need to develop practical approaches for detecting coronary atherosclerosis at an early stage for early initiation of appropriate treatment. To improve the identification of diabetic patients at high risk of cardiovascular events, single photon emission computed tomography myocardial perfusion, the CAC score, and MSCT coronary angiography have been proposed. 3 -5 However, these techniques may be limited available and associated with non-negligible radiation exposure, specially taking into account that periodical screening exams are often performed in the diabetic population. Possibly, routine screening for subclinical LV dysfunction with 2D speckle tracking echocardiography can be the first line approach to identify those patients with higher likelihood of coronary atherosclerosis who need further clinical explorations.
Conclusions
Subclinical LV systolic dysfunction is independently related to the presence of subclinical coronary atherosclerosis in asymptomatic patients with type 2 diabetes. In addition, subclinical LV systolic dysfunction had significant incremental value over other baseline patient characteristics in predicting coronary atherosclerosis.
